With a manufacturing facility in China, Utah-based ATL Technology was forced to deal with COVID months before the pandemic hit the United States. In this episode BioUtah’s president & CEO Kelvyn Cullimore interviews Brad Brown, CEO of ATL Technology and discusses how their dealings with the pandemic in China helped them prepare for and deal with COVID-19’s impact on a life sciences company.
Other topics discussed include:
- Long-term impacts of U.S. tariffs
- Pivoting for COVID
- Product development
- Much more